Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • seqadmin
    Senior Member
    • Oct 2022
    • 729

    #1

    Advancing RNA Liquid Biopsy Technology via Nanopore Sequencing

    Join our upcoming webinar to explore the innovative world of RNA liquid biopsies. Learn how the advanced COMPLETE-seq technology utilizes nanopore sequencing to detect full-length, cell-free RNAs from cancer patients, revealing thousands of novel RNA sequences.

    Click image for larger version  Name:	SEQ Oxford Nanopore Live Webinar September 12th 2024-title page.jpg Views:	0 Size:	378.3 KB ID:	326003



    In this webinar you’ll learn how:
    • RNA liquid biopsy technology enables highly sensitive and specific cancer detection in a minimally invasive way
    • Repetitive cell-free RNAs are enriched in cancer patients and can be leveraged to improve disease classification
    • Nanopore sequencing reveals full-length cell-free RNAs, including thousands of novel and disease-specific RNAs
    Who should attend:
    • Cancer researchers
    • Genomics researchers
    • Diagnostics researchers
    • RNA researchers
    Register now to understand how RNA liquid biopsies are transforming cancer diagnostics.​

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...